<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D64641C7-D9A6-4B41-9C8F-03F7396CB8DA"><gtr:id>D64641C7-D9A6-4B41-9C8F-03F7396CB8DA</gtr:id><gtr:name>University of Lincoln</gtr:name><gtr:department>Lincoln School of Engineering</gtr:department><gtr:address><gtr:line1>Brayford Pool</gtr:line1><gtr:postCode>LN6 7TS</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D64641C7-D9A6-4B41-9C8F-03F7396CB8DA"><gtr:id>D64641C7-D9A6-4B41-9C8F-03F7396CB8DA</gtr:id><gtr:name>University of Lincoln</gtr:name><gtr:address><gtr:line1>Brayford Pool</gtr:line1><gtr:postCode>LN6 7TS</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C78A3757-DBEB-4749-B986-5195E1F3B6C6"><gtr:id>C78A3757-DBEB-4749-B986-5195E1F3B6C6</gtr:id><gtr:firstName>Renato</gtr:firstName><gtr:surname>Turchetta</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0275454D-4FEC-4FDE-8A13-6ED31A4D624A"><gtr:id>0275454D-4FEC-4FDE-8A13-6ED31A4D624A</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CC850759-8CDD-40F3-A416-CD99DAA252AD"><gtr:id>CC850759-8CDD-40F3-A416-CD99DAA252AD</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Speller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E67D0550-C449-474A-99FD-7EE48EF4BFCE"><gtr:id>E67D0550-C449-474A-99FD-7EE48EF4BFCE</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Wells</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C7519CCA-F85C-4D10-8C03-F2FC394B4711"><gtr:id>C7519CCA-F85C-4D10-8C03-F2FC394B4711</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Allinson</gtr:surname><gtr:orcidId>0000-0002-4775-8332</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FG037671%2F2"><gtr:id>E2D020DF-EBF5-4323-9FFA-406B5FDE0FC4</gtr:id><gtr:title>MI-3 Plus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G037671/2</gtr:grantReference><gtr:abstractText>CMOS Active Pixel Sensors (APS) are revolutionising many aspects of imaging with their superior performance, flexibility and close integration with the acquisition and processing requirements. Their progress is, in no small part, due to advances in mainstream CMOS technology. Industry is focussed on developing CMOS imagers for the mass markets such as digital cameras and mobile phones. Within MI-3, we brought together sufficient technology expertise and users to exploit APS technology for a broad range of science. This project, MI-3 Plus, will take forward one aspect of this technology - namely, the realisation of radiation-hard, wafer-scale imagers, approximately 12 cm square, specially designed for scientific and clinical use. In doing so, we directly address one of the challenges set out in the EPSRC Grand Challenges in Silicon Technology (2008) - Large imaging arrays for use in medical applications and imaging of explosives and weapons. Such large imagers will be able to cope with an accumulated radiation dose in excess of 10 MRad, be approximately 12 cm x 12 cm and incorporate programmable intra-frame resets and binning to cope with the wide dynamics of image intensity found in many medical/scientific applications. It would be possible to tile these imagers, with a minimum bonding gap, to produce torso-wide lensless systems for radiography, etc. The imagers, and the supporting acquisition systems, will be trialled in number of key application areas, namely:* Bone/breast radiography using laboratory and synchrotron sources * Structural crystallography on laboratory and synchrotron sources* High resolution and discriminatory baggage screening * Digital mammography, in particular tomosynthesis (3D imaging) * Radiation-hard very large area sensors for radiotherapy (x-ray and proton) The more general capabilities of CMOS technology can be exploited in miniature analytical instruments for medicine, life sciences, etc - the so-called Lab-on-a-chip concept. This is another topic that forms one of the EPSRC Grand Challenges. Through selective etching of our APS devices we will demonstrate the advantages of very efficient imaging - at high sensitivity and resolution - using this new approach.Overall, comparisons with existing methods will be rigorously undertaken; and the resulting systems will be widely demonstrated to their respective user communities and associated commercial system providers.</gtr:abstractText><gtr:fund><gtr:end>2013-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2011-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>989110</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1850000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PRaVDA (Proton Radiotherapy Verification and Dosimetry Applications)</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>098285</gtr:fundingRef><gtr:id>A74B2816-5600-4CB3-AEC7-5C0DAB5830A4</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Development of the World's first radiation-tolerant, wafer-scale (13 cm square) CMOS imager (Active Pixel Sensor) - Dynamite - which presents exciting new potential for medical, scientific and technological imaging with much improved performance and lower life-time costs. This development fully met a Grand Challenge set by EPSRC and the imager, called Dynamite, is being exploited in on-going trials for prostate cancer radiotherapy at the Royal Marsden Hospital/ICR and for diffraction-enhanced m</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>850A8CDE-76BD-4FAC-82CC-F0205298F8EC</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Electronics,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>MI-3 Plus, building upon previous work on CMOS Active Pixel Sensors, designed and realised a single imager on an industry standard 8&amp;quot; (200 mm) wafer. The imager, called Dynamite, is not only one of the largest imagers made but is the World's first radiation-hard wafer-scale imager. It is intended to meet demanding applications in x-ray medical imaging and other branches of biological/medical science. In producing this unique device, MI-3 Plus fully met one of EPSRC's Grand Challenges in Silicon</gtr:description><gtr:exploitationPathways>The most significant market for very large area CMOS imagers will be in medical diagnosis (and to a lesser extent in therapy). The current technology for &amp;quot;digital&amp;quot; radiography is flat-panels using amorphous silicon thin film transistors (as in LCD televisions) - they suffer from high noise, slow readout and high cost. Now that we have shown the ability to make, with high yield, very large area CMOS imagers that can tolerant the high radiation exposure to x-rays, CMOS will almost certainly beco</gtr:exploitationPathways><gtr:id>638F2667-BA0E-41E9-B294-E3F3233BCB3D</gtr:id><gtr:sectors><gtr:sector>Electronics,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D6FA54F-94E9-41DE-8374-9333A405C9D1"><gtr:id>7D6FA54F-94E9-41DE-8374-9333A405C9D1</gtr:id><gtr:title>Western blotting electrophoretic sequencing: First images with a room temperature CMOS detector</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c1d0b4ac448f84bce9255dfee0761ed"><gtr:id>5c1d0b4ac448f84bce9255dfee0761ed</gtr:id><gtr:otherNames>Esposito M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-4673-0118-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E1717F9-1FDB-475C-9ECF-1DA3025BFAAB"><gtr:id>1E1717F9-1FDB-475C-9ECF-1DA3025BFAAB</gtr:id><gtr:title>Using a large area CMOS APS for direct chemiluminescence detection in Western blotting electrophoresis</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c1d0b4ac448f84bce9255dfee0761ed"><gtr:id>5c1d0b4ac448f84bce9255dfee0761ed</gtr:id><gtr:otherNames>Esposito M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49CAAEB8-EBCD-4C74-B280-C45366B1DAAB"><gtr:id>49CAAEB8-EBCD-4C74-B280-C45366B1DAAB</gtr:id><gtr:title>CMOS APS in pre-clinical science: Next generation disruptive technology for multi-modality imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5c1d0b4ac448f84bce9255dfee0761ed"><gtr:id>5c1d0b4ac448f84bce9255dfee0761ed</gtr:id><gtr:otherNames>Esposito M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-2028-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2D097D8C-800F-4019-ACB3-3390E07EA60F"><gtr:id>2D097D8C-800F-4019-ACB3-3390E07EA60F</gtr:id><gtr:title>Medical Imaging 2012: Biomedical Applications in Molecular, Structual, and Functional Imaging : 5-7 February 2012, San Diego, California, United States</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/200b733281e9410bdd54931b61f32491"><gtr:id>200b733281e9410bdd54931b61f32491</gtr:id><gtr:otherNames>Molthen Robert</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9780819489661</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5560FF4-4780-4A5F-A5DC-38FD8FBFA0E9"><gtr:id>D5560FF4-4780-4A5F-A5DC-38FD8FBFA0E9</gtr:id><gtr:title>Proton-counting radiography for proton therapy: a proof of principle using CMOS APS technology.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02c42f4c52772605a810308c74fb5503"><gtr:id>02c42f4c52772605a810308c74fb5503</gtr:id><gtr:otherNames>Poludniowski G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C44E0B4-B2A6-461C-BD20-81B099E2D2CB"><gtr:id>2C44E0B4-B2A6-461C-BD20-81B099E2D2CB</gtr:id><gtr:title>Radiation hardness of a large area CMOS Active Pixel Sensor for bio-medical applications - ISDI White Paper</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8aac4998764dd4e0166ae612248b0366"><gtr:id>8aac4998764dd4e0166ae612248b0366</gtr:id><gtr:otherNames>Michela Esposito (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1C22027-A930-4AD3-83DF-F3AFC48D10CB"><gtr:id>A1C22027-A930-4AD3-83DF-F3AFC48D10CB</gtr:id><gtr:title>A novel wafer-scale CMOS APS X-ray detector for breast cancer diagnosis using X-ray diffraction studies</gtr:title><gtr:parentPublicationTitle>Journal of Instrumentation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dcd6f17ded5c9de7a013e0592d3cdc"><gtr:id>05dcd6f17ded5c9de7a013e0592d3cdc</gtr:id><gtr:otherNames>Konstantinidis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA728ECA-A47E-4517-BB5E-3BD4784CFD9B"><gtr:id>CA728ECA-A47E-4517-BB5E-3BD4784CFD9B</gtr:id><gtr:title>Evaluation of a novel wafer-scale CMOS APS X-ray detector for use in mammography</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dcd6f17ded5c9de7a013e0592d3cdc"><gtr:id>05dcd6f17ded5c9de7a013e0592d3cdc</gtr:id><gtr:otherNames>Konstantinidis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-2028-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8C46072-276E-4D0D-86FA-38962EC99D55"><gtr:id>B8C46072-276E-4D0D-86FA-38962EC99D55</gtr:id><gtr:title>DynAMITe: a prototype large area CMOS APS for breast cancer diagnosis using x-ray diffraction measurements</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/05dcd6f17ded5c9de7a013e0592d3cdc"><gtr:id>05dcd6f17ded5c9de7a013e0592d3cdc</gtr:id><gtr:otherNames>Konstantinidis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G037671/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>8C8BB633-468D-484A-8F89-4458ADFDE9F6</gtr:id><gtr:grantRef>EP/G037671/1</gtr:grantRef><gtr:amount>1195473.22</gtr:amount><gtr:start>2009-08-01</gtr:start><gtr:end>2011-01-01</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>E2D020DF-EBF5-4323-9FFA-406B5FDE0FC4</gtr:id><gtr:grantRef>EP/G037671/2</gtr:grantRef><gtr:amount>989110.18</gtr:amount><gtr:start>2011-01-01</gtr:start><gtr:end>2013-01-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>EB5F16BB-2772-4DDE-BD6C-3B7A6914B64C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Info. &amp; commun. Technol.</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>E847DD9B-2053-4BC7-97A9-4213B185C968</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Materials sciences</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>67935C1F-34EE-43B3-9BBC-F5A8E0FB2365</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Electronic Devices &amp; Subsys.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>561091A1-9FC9-4508-B1B2-2F3623E1FC9D</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Materials Characterisation</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1E31C833-3A35-4F54-A499-31D0C245B5D5</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>System on Chip</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>